Rodent model of metabolic dysfunction-associated fatty liver disease: a systematic review.
- 2024-09-25
- Journal of gastroenterology and hepatology 40(1)
- Xiao-Shan Cui
- Hong-Zheng Li
- Liang Li
- Cheng-Zhi Xie
- Jia-Ming Gao
- Yuan-Yuan Chen
- Hui-Yu Zhang
- Wei Hao
- Jian-Hua Fu
- Hao Guo
- PubMed: 39322221
- DOI: 10.1111/jgh.16749
Study Design
- Type
- Systematic Review
- Methods
- We conducted a comprehensive literature review of English-language original research articles published from 1990 to 2023, sourced from PubMed, Embase, and Web of Science, aiming to collate studies that provided a comparative analysis of physiological, metabolic, and hepatic histological characteristics between MASLD models and control groups.
Although significant progress has been made in developing preclinical models for metabolic dysfunction-associated steatotic liver disease (MASLD), few have encapsulated the essential biological and clinical outcome elements reflective of the human condition. We conducted a comprehensive literature review of English-language original research articles published from 1990 to 2023, sourced from PubMed, Embase, and Web of Science, aiming to collate studies that provided a comparative analysis of physiological, metabolic, and hepatic histological characteristics between MASLD models and control groups. The establishment of a robust metabolic dysfunction-associated steatotic liver rodent model hinges on various factors, including animal species and strains, sex, induction agents and methodologies, and the duration of induction. Through this review, we aim to guide researchers in selecting suitable induction methods and animal species for constructing preclinical models aligned with their specific research objectives and laboratory conditions. Future studies should strive to develop simple, reliable, and reproducible models, considering the model's sensitivity to factors such as light-dark cycles, housing conditions, and environmental temperature. Additionally, the potential of diverse in vitro models, including 3D models and liver organ technology, warrants further exploration as valuable tools for unraveling the cellular mechanisms underlying fatty liver disease.